Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Piet Ost

Showing results (61-70 of 334) with videos related to

Pageof 34
Sort By:
European Urology Focus|August 13, 2017
Exploring All Avenues for Radiotherapy in Oligorecurrent Prostate Cancer Disease Limited to Lymph Nodes: A Systematic Review of the Role of Stereotactic Body RadiotherapyElisabetta Ponti, Andrea Lancia, Piet Ost, et al.
The Lancet. Oncology|April 30, 2026
How flaws in study design and lead-time bias could affect the interpretation of data - Authors' replyChad Tang, Alexander D Sherry, Ryan Sun, et al.
European Urology Focus|September 23, 2022
The Emerging Role of Extracranial Stereotactic Ablative Radiotherapy for Metastatic Renal Cell Carcinoma: A Systematic ReviewJennifer Le Guevelou, Paul Sargos, Shankar Siva, et al.
Translational Andrology and Urology|September 18, 2020
How to deal with steroids use in the management of metastatic prostate cancer during pandemicMichael Baboudjian, Guillaume Ploussard, Shahrokh F Shariat, et al.
European Urology|September 14, 2025
Should We Embark on "EMBARK"? Reassessing the Role of Radiotherapy and Androgen Receptor Pathway Inhibitors in the Era of Next-generation ImagingGiulia Marvaso, Giulio Francolini, Vérane Achard, et al.
Acta Oncologica (Stockholm, Sweden)|November 12, 2014
Impact of changing rectal dose volume parameters over time on late rectal and urinary toxicity after high-dose intensity-modulated radiotherapy for prostate cancer: A 10-years single centre experienceValérie Fonteyne, Simin Sadeghi, Piet Ost, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|April 25, 2012
Hypofractionated frameless stereotactic intensity-modulated radiotherapy with whole brain radiotherapy for the treatment of 1-3 brain metastasesBruno De Potter, Gert De Meerleer, Wilfried De Neve, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 23, 2025
Incorporating indirect MRI information in a CT-based deep learning model for prostate auto-segmentationDaan Stas, Geert De Kerf, Michaël Claessens, et al.
Acta Clinica Belgica|November 28, 2018
Abiraterone and spironolactone in prostate cancer: a combination to avoidBert Dhondt, Sarah Buelens, Jeroen Van Besien, et al.
BMC Cancer|September 6, 2019
A phase III randomized-controlled, single-blind trial to improve quality of life with stereotactic body radiotherapy for patients with painful bone metastases (ROBOMET)Carole Mercier, Piet Dirix, Piet Ost, et al.
Pageof 34

Showing results (61-70 of 334) with videos related to

Sort By:
Pageof 34
European Urology Focus|August 13, 2017
Exploring All Avenues for Radiotherapy in Oligorecurrent Prostate Cancer Disease Limited to Lymph Nodes: A Systematic Review of the Role of Stereotactic Body RadiotherapyElisabetta Ponti, Andrea Lancia, Piet Ost, et al.
The Lancet. Oncology|April 30, 2026
How flaws in study design and lead-time bias could affect the interpretation of data - Authors' replyChad Tang, Alexander D Sherry, Ryan Sun, et al.
European Urology Focus|September 23, 2022
The Emerging Role of Extracranial Stereotactic Ablative Radiotherapy for Metastatic Renal Cell Carcinoma: A Systematic ReviewJennifer Le Guevelou, Paul Sargos, Shankar Siva, et al.
Translational Andrology and Urology|September 18, 2020
How to deal with steroids use in the management of metastatic prostate cancer during pandemicMichael Baboudjian, Guillaume Ploussard, Shahrokh F Shariat, et al.
European Urology|September 14, 2025
Should We Embark on "EMBARK"? Reassessing the Role of Radiotherapy and Androgen Receptor Pathway Inhibitors in the Era of Next-generation ImagingGiulia Marvaso, Giulio Francolini, Vérane Achard, et al.
Acta Oncologica (Stockholm, Sweden)|November 12, 2014
Impact of changing rectal dose volume parameters over time on late rectal and urinary toxicity after high-dose intensity-modulated radiotherapy for prostate cancer: A 10-years single centre experienceValérie Fonteyne, Simin Sadeghi, Piet Ost, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|April 25, 2012
Hypofractionated frameless stereotactic intensity-modulated radiotherapy with whole brain radiotherapy for the treatment of 1-3 brain metastasesBruno De Potter, Gert De Meerleer, Wilfried De Neve, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 23, 2025
Incorporating indirect MRI information in a CT-based deep learning model for prostate auto-segmentationDaan Stas, Geert De Kerf, Michaël Claessens, et al.
Acta Clinica Belgica|November 28, 2018
Abiraterone and spironolactone in prostate cancer: a combination to avoidBert Dhondt, Sarah Buelens, Jeroen Van Besien, et al.
BMC Cancer|September 6, 2019
A phase III randomized-controlled, single-blind trial to improve quality of life with stereotactic body radiotherapy for patients with painful bone metastases (ROBOMET)Carole Mercier, Piet Dirix, Piet Ost, et al.
Pageof 34